Figure 1From: Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trialsOutline of the search - Flow diagram. RCTs: randomized clinical trials; pts: patients; PFS: progression free survival; OS: overall survival; ORR: overall response rate; HTN: hypertension; neuro: neurotixicity; FN: febrile neutropenia; GI: gastro-intestinal.Back to article page